Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 2,182,121 $ 2,431,299
Investment in securities at fair value 1,120,482 647,363
Accounts receivable, net 1,800
Other receivable 15,000
Note Receivable 1,000,000
Prepaid expenses and other current assets 7,010 6,508
Total current assets 3,309,613 4,101,970
Property and equipment    
Property and equipment 48,239 48,239
Accumulated depreciation and amortization (47,721) (46,648)
Property and equipment, net 518 1,591
Other assets    
Investment in account receivable, net of discount and current portion 238,849
Long term investments 104,431 104,431
Total other assets 104,431 343,280
Total assets 3,414,562 4,446,841
Current liabilities    
Accounts payable 3,166 3,152
Accrued expenses 42,599 91,460
Total current liabilities 45,765 94,612
Long-term liabilities    
Accrued salary, retirement, and incentive fee-related party 476,578 436,512
Total long-term liabilities 476,578 436,512
Total liabilities 522,343 531,124
Commitments and Contingencies (Note 16)
Shareholders’ equity    
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 11 and 11 series Q preferred shares issued and outstanding at December 31, 2024 and 2023 [1]  
Common stock, $0.0001 par value, 75,000,000 shares authorized; 21,686,105 and 24,686,105 shares issued and outstanding at December 31, 2024 and 2023 2,169 2,469
Additional paid in capital 11,917,362 12,101,055
Accumulated deficit (9,027,312) (8,187,807)
Total shareholders’ equity 2,892,219 3,915,717
Total liabilities and shareholders’ equity $ 3,414,562 $ 4,446,841
[1] Par value is less than $0.01